Clinical Trial Detail

NCT ID NCT02705339
Title Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Washington University School of Medicine
Indications

lung adenocarcinoma

Therapies

Rociletinib

Age Groups: adult

Additional content available in CKB BOOST